PROEHL GERALD T - 29 Jan 2026 SCHEDULE 13D/A Report for Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA)

Filing Manager: PROEHL GERALD T
Reporting Manager: PROEHL GERALD T
Security: Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share.
Symbol: DRMA
Shares outstanding: 3,543,755 shares
Disclosed Ownership: 694,576 shares
Ownership: 20%
Form type: SCHEDULE 13D/A
Filing time: 02 Feb 2026, 18:35:13 UTC
Date of event: 29 Jan 2026
Previous filing: 08 Jan 2026
Next filing: 23 Feb 2026
SEC: View on sec.gov

Key filing fact

PROEHL GERALD T disclosed 20% ownership in Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA) on 29 Jan 2026.

Key facts

PROEHL GERALD T filed SCHEDULE 13D/A for Dermata Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share. (DRMA).
Disclosed ownership: 20%.
Date of event: 29 Jan 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
PROEHL GERALD T	20%	694,576	694,576	0	/s/ Gerald T. Proehl	Gerald T. Proehl	0001279191

CIK / CUSIP context first

Broader feeds